An alpha-melanocyte-stimulating-hormone analogue examined in an early pigmentation study.
In simple words
Melanotan 2, also called Melanotan II, is a synthetic analogue of a pigment-related hormone signal. The selected early human study examined pigmentation; a small trial does not establish safety for cosmetic use.
Melanotan-II is not the same compound as every other melanocortin analogue. A small early trial is not proof of cosmetic-use safety.
Evidence on studied compounds does not establish the identity, purity, safety, or regulatory approval of the catalogue vial. No Canadian regulatory status is assessed here.
Research questions about Melanotan 2
What is Melanotan 2?
Melanotan 2, also called Melanotan II, is a synthetic analogue of a pigment-related hormone signal. The selected early human study examined pigmentation; a small trial does not establish safety for cosmetic use.
What types of research are cited for Melanotan 2?
The Melanotan 2 profile contains the following selected evidence. This is not a systematic review or a complete inventory of research.
Melanotan-II: pilot phase 1 study (1996): Human — small pilot trial
Melanotan-II is not the same compound as every other melanocortin analogue. A small early trial is not proof of cosmetic-use safety.
What do the selected Melanotan 2 studies not establish?
Melanotan-II: pilot phase 1 study (1996): Nausea, fatigue/somnolence and spontaneous prolonged erections occurred. Three volunteers cannot establish cosmetic-use safety or long-term risk.
These studies do not establish the identity, purity, safety or effects of the MXC Melanotan 2 vial. Findings in one formulation, population or experimental model should not be assumed to apply to another.